RG
Rathbones Group’s Guardant Health GH Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $10.7M | Buy |
205,965
+3,838
| +2% | +$200K | 0.05% | 158 |
|
2025
Q1 | $8.61M | Buy |
202,127
+3,166
| +2% | +$135K | 0.04% | 161 |
|
2024
Q4 | $6.08M | Buy |
198,961
+12,375
| +7% | +$378K | 0.03% | 186 |
|
2024
Q3 | $4.28M | Buy |
186,586
+78,191
| +72% | +$1.79M | 0.02% | 207 |
|
2024
Q2 | $3.13M | Buy |
108,395
+4,667
| +4% | +$135K | 0.02% | 225 |
|
2024
Q1 | $2.14M | Buy |
103,728
+8,050
| +8% | +$166K | 0.01% | 263 |
|
2023
Q4 | $2.59M | Sell |
95,678
-1,106
| -1% | -$29.9K | 0.02% | 239 |
|
2023
Q3 | $2.87M | Buy |
96,784
+2,347
| +2% | +$69.6K | 0.02% | 225 |
|
2023
Q2 | $3.38M | Sell |
94,437
-963
| -1% | -$34.5K | 0.03% | 168 |
|
2023
Q1 | $2.24M | Sell |
95,400
-3,119
| -3% | -$73.1K | 0.02% | 198 |
|
2022
Q4 | $2.68M | Sell |
98,519
-7,563
| -7% | -$206K | 0.03% | 186 |
|
2022
Q3 | $5.71M | Buy |
106,082
+242
| +0.2% | +$13K | 0.07% | 142 |
|
2022
Q2 | $4.27M | Sell |
105,840
-51
| -0% | -$2.06K | 0.05% | 159 |
|
2022
Q1 | $7.01M | Sell |
105,891
-387
| -0.4% | -$25.6K | 0.07% | 139 |
|
2021
Q4 | $10.6M | Buy |
106,278
+11,271
| +12% | +$1.13M | 0.1% | 123 |
|
2021
Q3 | $11.9M | Buy |
95,007
+17,156
| +22% | +$2.14M | 0.13% | 114 |
|
2021
Q2 | $9.67M | Buy |
77,851
+16,633
| +27% | +$2.07M | 0.11% | 122 |
|
2021
Q1 | $9.35M | Buy |
61,218
+23,513
| +62% | +$3.59M | 0.12% | 117 |
|
2020
Q4 | $4.86M | Buy |
37,705
+17,458
| +86% | +$2.25M | 0.07% | 141 |
|
2020
Q3 | $2.26M | Buy |
+20,247
| New | +$2.26M | 0.04% | 168 |
|